LEADER 01555nam  2200349   450 
001 9910688465503321
005 20230701012010.0
035   $a(CKB)5400000000044834
035   $a(NjHacI)995400000000044834
035   $a(EXLCZ)995400000000044834
100   $a20230701d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMetformin /$fAnca Pantea Stoian, Manfredi Rizzo, editor
210  1$aLondon :$cIntechOpen,$d2020.
215   $a1 online resource (242 pages)
311   $a1-83880-760-8 
330   $aThe book "Metformin" aims to bring to light new concepts and trends related to the many metformin therapeutic features. After a history of over 60 years, with moments of decline and spectacular returns, metformin can now be regarded as a universal panacea, the valences of its therapeutics being increasingly appreciated, both in the background treatment of diabetes and pre-diabetes, but also in reproductive pathology, cancer, cardiovascular disease, and antiageing. In this respect, the mechanisms of action and the pharmacodynamics of metformin seem to be incompletely known, a number of current studies have revealed new action valences.
606   $aMetformin
615  0$aMetformin.
676   $a615.3
702   $aRizzo$b Manfredi
702   $aStoian$b Anca Pantea
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688465503321
996   $aMetformin$91952071
997   $aUNINA